Atrial Fibrillation in Hypertrophic Cardiomyopathy

Atrial Fibrillation in Hypertrophic Cardiomyopathy

The current information about features of atrial fibrillation in patients with hypertrophic cardiomyopathy is presented in this review. The data about prevalence, pathogenesis and its various complications in these patients are disclosed. The article contains updated clinical recommendations of auth...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. A. Ignatenko, G. G. Taradin, N. T. Vatutin, A. A. Kaluga, Yu. D. Kostyamin
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2021-05-01
Series:	Архивъ внутренней медицины
Subjects:	hypertrophic cardiomyopathy cardiac arrhythmias atrial fibrillation risk factors anticoagulant therapy antiarrhythmic therapy left ventricular outflow tract obstruction catheter ablation
Online Access:	https://www.medarhive.ru/jour/article/view/1233
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Septal alcohol ablation in patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction
by: Mariia S. Nozdriakova, et al.
Published: (2025-01-01)

THE UNRESOLVED ISSUES AND MODERN VIEW ON ATRIAL FIBRILLATION PATIENTS MANAGEMENT
by: D. V. Losik, et al.
Published: (2017-08-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years
by: Daniele Massera, et al.
Published: (2025-01-01)

Mavacamten in real‐life practice: Initial experience at a hypertrophic cardiomyopathy centre
by: Zaid Abood, et al.
Published: (2025-02-01)

Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities
by: Marco Maria Dicorato, et al.
Published: (2025-05-01)

Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021-09-01)

The results of alcohol septal ablation in patients with hypertrophic cardiomiopathy and arterial hypertension
by: K. V. Rudenko, et al.
Published: (2020-02-01)

Daily Heart Rate Variability in Dogs With Atrial Fibrillation
by: Joao Escalda, et al.
Published: (2025-03-01)

HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01)

Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan
by: Hiroaki Kitaoka, et al.
Published: (2025-02-01)

Effect of salt intake on clinical course and hemodynamics in patients with hypertrophic cardiomyopathy
by: N. G. Poteshkina, et al.
Published: (2022-01-01)

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
by: Tatiana Saul, et al.
Published: (2024-12-01)

High‐frequency content within the QRS complex can predict ventricular tachyarrhythmias in hypertrophic cardiomyopathy
by: Takeshi Tsutsumi, et al.
Published: (2025-08-01)

Microvascular dysfunction causing myocardial ischemia in obstructive hypertrophic cardiomyopathy
by: Nonthikorn Theerasuwipakorn, MD, MSc, et al.
Published: (2025-04-01)

ATRIAL FIBRILLATION AND FLUTTER IN HYPERTROPHIC CARDIOMYOPATHY
by: N. S. Krylova, et al.
Published: (2015-05-01)

A case report of ventricular suicide following transcatheter aortic valve replacement for severe aortic stenosis in a patient with hypertrophic cardiomyopathy: the danger of abrupt afterload reduction
by: Kirtivardhan Vashistha, et al.
Published: (2025-06-01)

The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy
by: Luca Pugliese, et al.
Published: (2025-05-01)

2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
by: S. A. Gabrusenko, et al.
Published: (2021-06-01)

Prevalence of Atrial Fibrillation and Intervention Therapy in Cardiac Amyloidosis
by: Runzhe Wu, et al.
Published: (2025-05-01)

FEATURES OF DIAGNOSTIC AND MEDICALLY INVASIVE MANAGEMENT OF FREQUENTLY RECURRENT POLYMORPHIC, POLYTOPIC VENTRICULAR TACHYCARDIA
by: T.V. Dubrovinska, et al.
Published: (2021-04-01)

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
by: Anjali T. Owens, et al.
Published: (2024-09-01)

Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy
by: G. I. Ignatenko, et al.
Published: (2023-08-01)

Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature)
by: A. A. Streltsova, et al.
Published: (2021-10-01)

Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment
by: Laura Adina Stanciulescu, et al.
Published: (2025-02-01)

Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy
by: Anne M. Dybro, et al.
Published: (2025-08-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

The role of cardiac MRI in risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy
by: M. S. Ishchenko, et al.
Published: (2024-05-01)

Right ventricular dysfunction improves prediction of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance study
by: Shengxu Li, et al.
Published: (2025-06-01)

A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy
by: Ian Ogurek, et al.
Published: (2025-05-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

LEFT VENTRICULAR WALL THICKNESS AND AUTONOMIC REGULATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: O. Allaberganov, et al.
Published: (2011-10-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

Prevention of atrial tachyarrhythmia in post-operation period of pulmonary veins ostia catheter isolation in paroxysmal atrial fibrillation
by: A. V. Tarasov, et al.
Published: (2016-10-01)

Premature ventricular contractions in children: classification, approaches to observation and treatment
by: T. K. Kruchina, et al.
Published: (2021-06-01)

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
by: M. G. Arakelyan, et al.
Published: (2021-08-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

Mid-Cavitary Obstruction in Hypertrophic Cardiomyopathy (HCM): A Rare Case Report and Management Approach
by: Rajeev Bharadwaj, et al.
Published: (2025-04-01)

Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
by: Nirav Patel, et al.
Published: (2024-11-01)

Pulsed field ablation for ventricular arrhythmias with pentaspline catheter
by: Anna Padisak, et al.
Published: (2025-07-01)